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Pharmaceutical industry is known as the “never fading sunrise industry”, which 
requires combination of advanced technology and craft. Application of new 
technology and new materials expanded the areas of research on rare diseases, which 
provides ways for curing life threatening diseases of human. The advancement on 
pharmaceutical technology also revolutionize the pharmaceutical industry and 
sustains a rapid development. In China, the rapid growth and development of 
pharmaceutical and healthcare industry is facilitated by the following factors: the 
increase of per capita disposable income and purchasing power; the rising aging 
population; the continuous investment by the government; the increased 
understanding of and concern on personal health among the general population; and 
their rising demand for healthcare products, all these factors have.  
 
Lansen Pharmaceutical Holdings Limited (“Lansen Pharma” or the “Company”) 
is engaged in the manufacture, distribution and development of specialty prescription 
western drugs for treatment of autoimmune disorder in rheumatology. Rheumatology is 
a fast growing medical discipline in China with huge capacity in market segment. 
 
This paper applies the Harvard Analytical Framework to analyze the industry 
background and development strategies of Lansen Pharma. Based on the financial 
statements and relevant data from year 2008 to 2014, the paper evaluates the financial 
position of Lansen Pharma in the view of liquidity, rate of return, profitability and 
cash flow. The paper discusses the business risk and strategic deficiencies of Lansen 
Pharma, and provides the possible recommendations based on the expected prospects 
of the Company. It is believed that this paper would be a good reference for the 
long-term development of Lansen Pharma and other comparable enterprises.  
 















potential, and the Company also has a clear and pragmatic vision and business 
strategies. However, during the implementation of the business strategies, the 
Company appears to focus on the short-term profit rather than the long-term 
sustainable development. It is recommended that the Company should make timely 
adjustments to avoid the risk of future stagnation or even downsizing.  
 
Keywords: Harvard Analytical Framework; Financial Analysis; Development 
Strategies; Lansen Pharma. 
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第一章  绪论 





















如 H 股上市公司朗生医药和康哲药业。 
在医药行业蓬勃发展的大背景下，众多医药企业赢得了先发优势，积累了
在细分市场主导地位的优质药品和丰厚的资本实力。然而在市场持续发展的长
                                                 





































长率仅为 8%，年度净利润率由 17%下降到了 12%4，市值亦无增长。纵观国内外
资本市场的众多上市公司的发展历程，像朗生医药这样上市后发展速度不够理
想的企业也不在少数。因此，无论从理论还是实践的角度，以朗生医药为例进
                                                 
2 医药经济报，朗生医药香港上市创超额认购记录，2010 年 5 月 17 日 
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